FDA Grants Orphan Designation to EXG110 for Fabry Disease
03 Dec 2024 //
BUSINESSWIRE
Exegenesis Bio to Present EXG001-307 Gene Therapy Data in SMA Type 1
25 Apr 2024 //
BUSINESSWIRE
Exegenesis Bio To Present Five Posters at ASGCT 26th Annual Meeting
05 Apr 2023 //
BUSINESSWIRE